Answers are grounded in this paper and cite their sources.
This analysis demonstrates the direct binding of human herpesvirus 8 chemokines to their receptors, suggesting new therapeutic avenues for infection.
Some viruses encode proteins that mimic host chemokines and/or cytokines to modulate the host immune responses against infection. Human herpesvirus 8 (HHV-8), also termed Kaposi sarcoma-associated herpesvirus (KSHV), encodes three viral CC-type chemokines (vCCLs 1–3) and an interleukin-6 ortholog (vIL-6). Therapeutic targeting of the vCCLs and vIL-6 has yet to be established despite their importance in immune evasion and transformation by HHV-8. The present study aimed to design a robust and straightforward method to assay receptor binding and downstream signaling using a Nano-Luciferase Binary Technology reporter system (NanoBiT); with this approach, we verified the direct interactions of vCCLs 1–3 with their established receptors. Furthermore, screening with a comprehensive set of human chemokine receptors revealed additional vCCL-interacting receptors, including ACKR4. The vCCL-receptor interactions were validated using competition, antibody-mediated neutralization, or mutagenesis of vCCLs. We extended the utility of NanoBiT to assess the intracellular protein-protein interactions involved in vCCL-induced downstream signaling via b-arrestin. Likewise, we used NanoBiT to monitor vIL-6 binding to its receptor gp130 and downstream signaling via STAT3. In sum, we demonstrate the utility of NanoBiT for assessing viral chemo/cytokine-receptor interactions and signaling and its potential in screening for antibodies to treat HHV-8 infection and related diseases.
No takes yet. Share an insight, caveat, or question.
Palande et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: